Oncolytics Biotech (ONC) Competitors C$1.39 -0.01 (-0.71%) (As of 01:20 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider Trades ONC vs. PLI, ABCN, EMC, FRX, BCT, IPA, MDNA, COV, SCYB, and COMShould you be buying Oncolytics Biotech stock or one of its competitors? The main competitors of Oncolytics Biotech include ProMetic Life Sciences (PLI), VIVO Cannabis (ABCN), Emblem (EMC), Fennec Pharmaceuticals (FRX), BriaCell Therapeutics (BCT), ImmunoPrecise Antibodies (IPA), Medicenna Therapeutics (MDNA), Covalon Technologies (COV), Scythian Biosciences (SCYB), and 138267 (COM.TO) (COM). These companies are all part of the "biotechnology" industry. Oncolytics Biotech vs. ProMetic Life Sciences VIVO Cannabis Emblem Fennec Pharmaceuticals BriaCell Therapeutics ImmunoPrecise Antibodies Medicenna Therapeutics Covalon Technologies Scythian Biosciences 138267 (COM.TO) ProMetic Life Sciences (TSE:PLI) and Oncolytics Biotech (TSE:ONC) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their community ranking, earnings, profitability, analyst recommendations, valuation, institutional ownership, media sentiment, dividends and risk. Which has preferable earnings and valuation, PLI or ONC? Oncolytics Biotech has lower revenue, but higher earnings than ProMetic Life Sciences. Oncolytics Biotech is trading at a lower price-to-earnings ratio than ProMetic Life Sciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioProMetic Life SciencesC$39.91M0.00-C$1.47B-C$63.06N/AOncolytics BiotechN/AN/A-C$28.02M-C$0.38-3.68 Is PLI or ONC more profitable? ProMetic Life Sciences' return on equity of 0.00% beat Oncolytics Biotech's return on equity.Company Net Margins Return on Equity Return on Assets ProMetic Life SciencesN/A N/A N/A Oncolytics Biotech N/A -138.22%-71.33% Do institutionals & insiders believe in PLI or ONC? 1.8% of Oncolytics Biotech shares are held by institutional investors. 3.8% of Oncolytics Biotech shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Does the MarketBeat Community favor PLI or ONC? ProMetic Life Sciences received 246 more outperform votes than Oncolytics Biotech when rated by MarketBeat users. However, 74.81% of users gave Oncolytics Biotech an outperform vote while only 67.69% of users gave ProMetic Life Sciences an outperform vote. CompanyUnderperformOutperformProMetic Life SciencesOutperform Votes44267.69% Underperform Votes21132.31% Oncolytics BiotechOutperform Votes19674.81% Underperform Votes6625.19% Does the media favor PLI or ONC? In the previous week, Oncolytics Biotech had 30 more articles in the media than ProMetic Life Sciences. MarketBeat recorded 30 mentions for Oncolytics Biotech and 0 mentions for ProMetic Life Sciences. Oncolytics Biotech's average media sentiment score of 0.08 beat ProMetic Life Sciences' score of 0.00 indicating that Oncolytics Biotech is being referred to more favorably in the news media. Company Overall Sentiment ProMetic Life Sciences Neutral Oncolytics Biotech Neutral Do analysts rate PLI or ONC? Oncolytics Biotech has a consensus target price of C$3.50, indicating a potential upside of 150.00%. Given Oncolytics Biotech's stronger consensus rating and higher possible upside, analysts clearly believe Oncolytics Biotech is more favorable than ProMetic Life Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ProMetic Life Sciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Oncolytics Biotech 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryOncolytics Biotech beats ProMetic Life Sciences on 10 of the 15 factors compared between the two stocks. Ad WealthPressBreaking News: Tesla headed to $500…That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla. So to claim your free digital copy today, simply follow this link and enter your email address. Get Oncolytics Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for ONC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ONC vs. The Competition Export to ExcelMetricOncolytics BiotechBiotechnology IndustryMedical SectorTSE ExchangeMarket CapC$107.60MC$164.72MC$5.03BC$6.25BDividend Yield0.31%3.25%5.16%5.27%P/E Ratio-3.68329.48135.4126.85Price / SalesN/A14,950.821,160.971,531.29Price / Cash4.2211.6733.5383.81Price / Book5.837.114.673.15Net Income-C$28.02M-C$18.52MC$119.07MC$299.38M7 Day Performance-0.71%-0.29%-1.83%0.76%1 Month Performance-20.45%8.30%-3.60%12.82%1 Year Performance-33.96%26.25%31.66%44.03% Oncolytics Biotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ONCOncolytics Biotech1.4019 of 5 starsC$1.39-0.7%C$3.50+151.8%-34.6%C$106.84MN/A-3.6629Analyst RevisionPLIProMetic Life SciencesN/AN/AN/AN/AC$317.06MC$39.91M-0.22487ABCNVIVO CannabisN/AC$1.32+5.6%N/A+0.0%C$256.62MN/A0.00N/AGap UpEMCEmblemN/A$1.88+1.6%N/A+0.0%$245.45M$5.71M-9.89N/AFRXFennec PharmaceuticalsN/AC$6.82+4.9%N/A-42.5%C$186.60MC$48.89M64.7010Analyst UpgradeNews CoverageGap UpBCTBriaCell TherapeuticsN/AC$10.60-3.8%C$15.00+41.5%+0.0%C$168.68MN/A-28.195IPAImmunoPrecise AntibodiesN/AC$6.50+0.8%N/A+0.0%C$162.08MC$19.47M-7.3080Gap DownMDNAMedicenna TherapeuticsN/AC$1.50flatN/A+252.9%C$114.65MN/A-3.9520Gap UpCOVCovalon TechnologiesN/AC$3.83-1.8%N/A+271.4%C$104.94MC$29.20M-97.50N/ASCYBScythian BiosciencesN/AC$3.49-5.9%N/A+0.0%C$102.38MN/A0.00N/AHigh Trading VolumeCOM138267 (COM.TO)N/AN/AN/A+0.0%C$102.19MN/A0.00N/A Related Companies and Tools Related Companies ProMetic Life Sciences Alternatives VIVO Cannabis Alternatives Emblem Alternatives Fennec Pharmaceuticals Alternatives BriaCell Therapeutics Alternatives ImmunoPrecise Antibodies Alternatives Medicenna Therapeutics Alternatives Covalon Technologies Alternatives Scythian Biosciences Alternatives 138267 (COM.TO) Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (TSE:ONC) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oncolytics Biotech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oncolytics Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
